Cloud-Based Platform Enlists Quest to Provide COVID-19 Molecular Test Results to Travelers

As proof of COVID-19 vaccination and/or negative molecular test results morphs into a passport for air travel and attending live events, labs with the capacity to generate rapid and reliable tests and results on an expansive geographic scale will be in growing demand. Quest Diagnostics has been quick to recognize and take advantage of this opportunity by enlisting as a test provider for TrustAssure. 

The TrustAssure Platform

Created by CLX Health, a developer of cloud-based solutions owned by SiriusIQ, the TrustAssure Global Testing Platform collaborates with physicians, clinics, hospitals and other providers in 5,000 U.S. and 15,000 global locations to provide test results to travelers and meeting attendees needing COVID-19 clearance to go through with their plans. Quest will become the first national provider of molecular COVID-19 testing to participate in TrustAssure. 

The newly announced Quest/CLX Health collaboration will enable individuals to use the TrustAssure platform to schedule test appointments at Quest patient centers and more than 750 retail pharmacy partner locations across the country knowing that they’ll get their results within 48 hours. This way, they can secure the “passport” they need to fly or attend the event in advance.   

It’s an ideal strategic collaboration: CLX Health secures Quest’s massive molecular testing capabilities to bolster its solution; in turn, Quest gets to leverage the TrustAssure platform, which integrates the IBM Digital Health Pass, to reach the air travel and live events markets.
“COVID-19 testing is a powerful tool for providing insights that can foster safer environments,” noted Cathy Doherty, Quest senior VP and group executive, clinical franchise solutions and marketing. “As COVID-19 restrictions are lifted around the country and world, our collaboration with TrustAssure will allow us to facilitate high-quality testing for individuals looking to get back to recreation and travel.” 

This is hardly Quest’s first venture into consumer empowerment over lab test results. The company was among the first diagnostic information services provider to offer free online access to test results. The lab giant also offers the MyQuest mobile app and patient portal enabling consumers to access and track their test results, as well as the QuestDirect service providing tests for various health conditions, illnesses and infections.

**************

This article originally appeared in G2 Intelligence, Laboratory Industry Report, August 2021.